Pollyea D, Kerre T, Deeren D, Beguin Y, et al. Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia. Leukemia 2025 Sep 15. doi: 10.1038/s41375-025-02767.
PMID: 40954213